Maya Zigler

Title: Innovations by Maya Zigler in Cancer Treatment

Introduction

Maya Zigler is an accomplished inventor based in Neve Ilan, Israel. She has made significant contributions to the field of cancer treatment, particularly in addressing castration-resistant prostate cancer (CRPC). With a total of four patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Maya Zigler's latest patents focus on advanced methods for treating CRPC. One of her notable inventions involves a polyplex that combines double-stranded RNA (dsRNA) with a polymeric conjugate. This conjugate consists of linear polyethyleneimine (LPEI) linked to polyethylene glycol (PEG) moieties, which are further connected to targeting moieties capable of binding to prostate surface membrane antigen (PSMA). This innovative approach aims to enhance the effectiveness of treatments for CRPC. Additionally, she has developed a method of treating cancer that includes administering this polyplex, showcasing her commitment to advancing cancer therapies.

Career Highlights

Maya Zigler has established herself as a key figure in the biotechnology sector. Her work at Targimmune Therapeutics AG has allowed her to collaborate with leading experts in the field. Her innovative research and patent contributions have positioned her as a prominent inventor in cancer treatment.

Collaborations

Maya has worked alongside talented colleagues, including Alexei Shir and Yael Langut. Their collaborative efforts have further enriched her research and development initiatives.

Conclusion

Maya Zigler's contributions to cancer treatment through her innovative patents demonstrate her dedication to improving patient outcomes. Her work continues to inspire advancements in the medical field.